Concepedia

Publication | Open Access

The Incidence of Ototoxicity in Patients Using Iron Chelators

15

Citations

8

References

2016

Year

Abstract

The ototoxicity incidence with DFO at doses below 50 mg/kg/day was 27.3%. Deferiprone and deferasirox were not associated with ototoxic effects in patients taking these drugs.

References

YearCitations

Page 1